Risk Factors for Short-term Adverse Events and Readmission After Arthroscopic Meniscectomy Does Age Matter?

被引:36
|
作者
Basques, Bryce A. [1 ]
Gardner, Elizabeth C. [1 ]
Varthi, Arya G. [1 ]
Fu, Michael C. [1 ]
Bohl, Daniel D. [1 ]
Golinvaux, Nicholas S. [1 ]
Grauer, Jonathan N. [1 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT 06510 USA
来源
AMERICAN JOURNAL OF SPORTS MEDICINE | 2015年 / 43卷 / 01期
基金
美国国家卫生研究院;
关键词
meniscectomy; outcomes; age; complications; readmission; QUALITY IMPROVEMENT PROGRAM; PARTIAL MEDIAL MENISCECTOMY; POSTOPERATIVE COMPLICATIONS; KNEE ARTHROSCOPY; OLDER POPULATION; MENISCAL TEAR; UNITED-STATES; SURGERY; ARTHROPLASTY; OUTCOMES;
D O I
10.1177/0363546514551923
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Recent studies have questioned the efficacy of meniscectomy in older patients with and without evidence of osteoarthritis; however, it continues to be frequently performed. There is limited information about age and other risk factors for adverse events and readmission after the procedure. This knowledge is vital to understand the true risk profile of this common surgery. Purpose: To investigate if age and medical comorbidities were risk factors for postoperative adverse events and readmission after meniscectomy. Study Design: Case-control study; Level of evidence, 3. Methods: Patients who underwent arthroscopic meniscectomy between 2005 and 2012 were identified from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database. Age 65 years and medical comorbidities were evaluated as risk factors for any adverse event (AAE), severe adverse events (SAEs), and readmission after meniscectomy using univariate and multivariate analyses. Results: A total of 17,774 patients who underwent meniscectomy were identified. The mean age was 53.0 13.6 years. A total of 3420 patients (19.2%) were 65 years. Overall, 208 patients (1.17%) had AAE, 203 patients (1.14%) had an SAE, and 102 patients were readmitted (0.97%). Multivariate logistic regression analyses demonstrated no significant differences between age groups for the occurrence of AAE, SAEs, and readmission. Patients with American Society of Anesthesiologists classification 3 had increased odds of AAE (odds ratio [OR], 1.58), SAEs (OR, 1.59), and readmission (OR, 1.99). Patients with diabetes had increased odds of AAE (OR, 1.57) and SAEs (OR, 1.51). Smokers had increased odds of readmission (OR, 1.67). Patients with pulmonary disease had increased odds of AAE (OR, 1.76) and SAEs (OR, 1.70). Conclusion: Meniscectomy is a safe procedure in older patients, as age over 65 years did not increase the odds of any of the adverse events studied. However, regardless of age, patients with an increased comorbidity burden and those with a history of smoking are at increased risk of adverse events and/or readmission after the procedure. Clinical Relevance: Knowledge of these risk factors for adverse events and readmission provides essential information for patient selection and preoperative counseling.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [31] Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
    Luuk Wieske
    Laura Y. L. Kummer
    Koos P. J. van Dam
    Eileen W. Stalman
    Anneke J. van der Kooi
    Joost Raaphorst
    Mark Löwenberg
    R. Bart Takkenberg
    Adriaan G. Volkers
    Geert R. A. M. D’Haens
    Sander W. Tas
    Phyllis I. Spuls
    Marcel W. Bekkenk
    Annelie H. Musters
    Nicoline F. Post
    Angela L. Bosma
    Marc L. Hilhorst
    Yosta Vegting
    Frederike J. Bemelman
    Joep Killestein
    Zoé L. E. van Kempen
    Alexandre E. Voskuyl
    Bo Broens
    Agner Parra Sanchez
    Gertjan Wolbink
    Laura Boekel
    Abraham Rutgers
    Karina de Leeuw
    Barbara Horváth
    Jan J. G. M. Verschuuren
    Annabel M. Ruiter
    Lotte van Ouwerkerk
    Diane van der Woude
    Cornelia F. Allaart
    Y. K. Onno Teng
    Pieter van Paassen
    Matthias H. Busch
    B. Papay Jallah
    Esther Brusse
    Pieter A. van Doorn
    Adája E. Baars
    Dirkjan Hijnen
    Corine R. G. Schreurs
    W. Ludo van der Pol
    H. Stephan Goedee
    Maurice Steenhuis
    Theo Rispens
    Anja ten Brinke
    Niels J. M. Verstegen
    Koos A. H. Zwinderman
    BMC Medicine, 20
  • [32] Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
    Wieske, Luuk
    Kummer, Laura Y. L.
    van Dam, Koos P. J.
    Stalman, Eileen W.
    van der Kooi, Anneke J.
    Raaphorst, Joost
    Lowenberg, Mark
    Takkenberg, R. Bart
    Volkers, Adriaan G.
    D'Haens, Geert R. A. M.
    Tas, Sander W.
    Spuls, Phyllis, I
    Bekkenk, Marcel W.
    Musters, Annelie H.
    Post, Nicoline F.
    Bosma, Angela L.
    Hilhorst, Marc L.
    Vegting, Yosta
    Bemelman, Frederike J.
    Killestein, Joep
    van Kempen, Zoe L. E.
    Voskuyl, Alexandre E.
    Broens, Bo
    Sanchez, Agner Parra
    Wolbink, Gertjan
    Boekel, Laura
    Rutgers, Abraham
    de Leeuw, Karina
    Horvath, Barbara
    Verschuuren, Jan J. G. M.
    Ruiter, Annabel M.
    van Ouwerkerk, Lotte
    van der Woude, Diane
    Allaart, Cornelia F.
    Teng, Y. K. Onno
    van Paassen, Pieter
    Busch, Matthias H.
    Jallah, B. Papay
    Brusse, Esther
    van Doorn, Pieter A.
    Baars, Adaja E.
    Hijnen, Dirkjan
    Schreurs, Corine R. G.
    van der Pol, W. Ludo
    Goedee, H. Stephan
    Steenhuis, Maurice
    Rispens, Theo
    Ten Brinke, Anja
    Verstegen, Niels J. M.
    Zwinderman, Koos A. H.
    BMC MEDICINE, 2022, 20 (01)
  • [33] Causes of Short-Term Readmission After Percutaneous Coronary Intervention
    Wasfy, Jason H.
    Strom, Jordan B.
    O'Brien, Cashel
    Zai, Adrian H.
    Luttrell, Jennifer
    Kennedy, Kevin F.
    Spertus, John A.
    Zelevinsky, Katya
    Normand, Sharon-Lise T.
    Mauri, Laura
    Yeh, Robert W.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (01) : 97 - 103
  • [35] SAFETY PROFILE OF OMEPRAZOLE - ADVERSE EVENTS WITH SHORT-TERM TREATMENT
    NELIS, GF
    DIGESTION, 1989, 44 : 68 - 76
  • [36] A clinical prediction rule for identifying short-term risk of adverse events in patients with pulmonary thromboembolism
    Uresandi, Fernando
    Otero, Remedios
    Cayuela, Aurelio
    Angel Cabezudo, Miguel
    Jimenez, David
    Laserna, Elena
    Conget, Francisco
    Oribe, Miquel
    Nauffal, Dolores
    ARCHIVOS DE BRONCONEUMOLOGIA, 2007, 43 (11): : 617 - 622
  • [37] National Evaluation of Short-Term and Intermediate-Term Readmission after Esophagectomy
    Yang, Chi-Fu J.
    Wang, Yoyo
    He, Hao
    Liou, Douglas
    Lui, Natalie
    Berry, Mark F.
    Shrager, Joseph
    Backhus, Leah
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S279 - S280
  • [38] Risk Factors and Short-Term Prognosis of Lymphocele After Kidney Transplant
    Hui, Yu
    Jiang, Hao
    Zhou, Zheng
    Hu, Linkun
    Wang, Liangliang
    Wei, Xuedong
    Huang, Yuhua
    Hou, Jianquan
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2023, 21 (10) : 807 - 813
  • [39] Adverse pregnancy outcomes and the development of short-term maternal cardiovascular disease risk factors
    Quist-Nelson, Johanna
    Meng, Marie Louise
    Stuart, Jennifer J.
    Fuller, Matthew
    Rogers, Ursula
    Pencina, Michael
    Rich-Edwards, Janet
    Henao, Ricardo
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S497 - S497
  • [40] ADVERSE EVENTS OF ERYTHROPOIETIN IN LONG-TERM AND IN ACUTE SHORT-TERM TREATMENT
    SINGBARTL, G
    CLINICAL INVESTIGATOR, 1994, 72 (06): : S36 - S43